Shy Therapeutics
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
7 Dana Rd, Valhalla, New York, 10595, Un...Website
www.shytherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Shy Therapeutics
SHY Therapeutics is focused on advancing small molecule therapeutics that target ATPases and GTPases, addressing significant unmet medical needs in critical disease areas. The company boasts a proprietary portfolio of unique small molecules that serve as both target discovery tools and starting points for therapeutic design. With a patient-centric approach, SHY aims to develop first-in-class programs that exceed current standards of care, leveraging collaborations with experienced pharmaceutical and biotechnology partners for late-stage development. Their innovative strategy combines machine learning and traditional methods to create a groundbreaking path for therapeutic innovation.Explore more
Popular SearchesShy Therapeutics LLCSHY TherapeuticsShytherapeuticsSIC Code 87,873NAICS Code 54,541Show more
Shy Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Shy Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Shy Therapeutics launches new products
Click to see if Shy Therapeutics had a recent Job posting/layoffs
Check out if Shy Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Shy Therapeutics
Check if Shy Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Shy Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Shy Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Shy Therapeutics recently announced quarterly report
Recommended Actions
Find VP level buyers at Shy Therapeutics
Find 3 more new buyers
Compare Similar Companies to Shy Therapeutics
Compare insights from companies similar to Shy Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Shy Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Shy Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Shy Therapeutics.
Shy Therapeutics Tech Stack
A closer look at the technologies used by Shy Therapeutics
Top Business Services Companies
Frequently Asked Questions Regarding Shy Therapeutics
Sign Up For FreeTo access detailed company insights
SHY Therapeutics is focused on advancing small molecule therapeutics that target ATPases and GTPases, addressing significant unmet medical needs in critical disease areas. The company boasts a proprietary portfolio of unique small molecules that serve as both target discovery tools and starting points for therapeutic design. With a patient-centric... Read More
